Immunology

Items 1-10 of 13

Page
per page
Set Descending Direction
  1. DLK1 (mouse):Fc (human) (rec.)
    AG-40A-0107Y
    AG-40A-0107Y-C01010 µg
    CHF 290.00
    AG-40A-0107Y-30103 x 10 µg
    CHF 575.00
    Replaces AG-40A-0107
    DLK1 (mouse):Fc (human) (rec.)
  2. DLL1 (mouse):Fc (human) (rec.)
    AG-40A-0148Y
    AG-40A-0148Y-C01010 µg
    CHF 180.00
    AG-40A-0148Y-C05050 µg
    CHF 370.00
    DLL1 (mouse):Fc (human) (rec.)
  3. DLL4 (human):Fc (human) (rec.) (highly active mutant)
    AG-40B-0176
    AG-40B-0176-C01010 µg
    CHF 350.00
    AG-40B-0176-C100100 µg
    CHF 1'080.00
    DLL4 (human):Fc (human) (rec.) (highly active mutant) (AG-40B-0176) binds to mNotch1 with higher affinity than WT DLL4:Fc. Method: Notch1 (mouse):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations
  4. Fc (human):FLT3 Ligand (human) (rec.)
    AG-40B-0119
    AG-40B-0119-C01010 µg
    CHF 240.00
    AG-40B-0119-30103 x 10 µg
    CHF 480.00
    AG-40B-0119-C100100 µg
    CHF 960.00
    Influence of FLT3L treatment on lymphocyte subpopulations. Method: C57BL/6 mice were injected intraperitoneally with 10 μg daily or were left untreated. (A) Percentages of indicated splenic subpopulations in FLT3L KO, WT control or WT-treated mice.
  5. FGF-2 (human) (rec.) (untagged)
    AG-40B-0150
    AG-40B-0150-C01010 µg
    CHF 120.00
    AG-40B-0150-30103 x 10 µg
    CHF 240.00
  6. Frizzled-5 (human):Fc (human) (rec.)
    AG-40B-0133
    AG-40B-0133-C05050 µg
    CHF 290.00
    AG-40B-0133-30503 x 50 µg
    CHF 575.00
    Figure: Frizzled-5 (human):Fc (human) (rec.) (AG-40B-0133) efficiently inhibits Wnt3a activation. Methods: Inhibition of Wnt3a activation by Frizzled-5 (human):Fc (human) (rec.) was measured by using HEK293 cells transfected with a plasmid c
  7. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed
  8. MFAP4 (human) (rec.)
    AG-40A-0072
    AG-40A-0072-C01010 µg
    CHF 215.00
    AG-40A-0072-C05050 µg
    CHF 540.00
  9. Notch1 (mouse):Fc (human) (rec.)
    AG-40B-0109
    AG-40B-0109-C05050 µg
    CHF 290.00
    AG-40B-0109-30503 x 50 µg
    CHF 575.00
  10. Notch2 (mouse):Fc (human) (rec.)
    AG-40B-0110
    AG-40B-0110-C05050 µg
    CHF 290.00
    AG-40B-0110-30503 x 50 µg
    CHF 575.00

Items 1-10 of 13

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.